...
首页> 外文期刊>Surgery today >Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection.
【24h】

Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection.

机译:给予FK506的大鼠心脏移植受者单核细胞亚群的变化用于治疗持续排斥反应。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The inhibitory effect of ongoing rejection and the changes that occurred in mononuclear cell subpopulations were compared between four groups of rats treated with FK506 or steroids. Group 1 was given no immunosuppressive drugs, group 2 was given FK506 from the day of grafting, group 3 was commenced on FK506 on the 4th day after grafting, and group 4 was commenced on methylprednisolone (MP) on the 4th day after grafting. The graft survival times in groups 2 and 3 were significantly longer than those in groups 1 and 4, and there were fewer CD3+ and CD4+ T lymphocytes in the peripheral blood in the groups treated with immunosuppressive drugs than in group 1. In group 4, the levels in both the peripheral blood and thymus were significantly lower than those in the groups treated with FK506 despite the fact that graft rejection occurred soon after the discontinuation of steroid administration. Moreover, the levels of interleukin-2 receptors and macrophages in groups 2, 3, and 4 were significantly lower than that in group 1 postoperatively; however, the number of macrophages in groups 2 and 3 was significantly lower than that in group 4 on the 10th day after transplantation. The findings of this study demonstrated that FK506, even if administered after rejection has begun, might inhibit the subsequent extensive allograft rejection more specifically and effectively than steroids, and that the measurement of a marker for macrophages in the peripheral blood could be useful for the detection of rejection following allograft transplantation in rats.
机译:比较了四组用FK506或类固醇治疗的大鼠的持续排斥反应的抑制作用和单核细胞亚群中发生的变化。第1组未给予免疫抑制药物,第2组从移植当天开始给予FK506,第3组在移植后第4天开始于FK506,第4组在移植后第4天开始接受甲基泼尼松龙(MP)。第2和第3组的移植物存活时间明显长于第1和第4组,并且用免疫抑制剂治疗的组的外周血CD3 +和CD4 + T淋巴细胞少于第1组。在第4组,尽管在停止类固醇给药后不久就发生了移植排斥,但外周血和胸腺中的血脂水平均显着低于FK506治疗组。此外,术后2、3和4组白细胞介素2受体和巨噬细胞的水平明显低于术后1组。然而,移植后第10天,第2组和第3组的巨噬细胞数量明显低于第4组。这项研究的结果表明,即使在排斥反应开始后施用FK506,也可能比类固醇更特异性和更有效地抑制随后的广泛同种异体移植排斥反应,并且外周血巨噬细胞标志物的测量可能对检测有用同种异体移植后排斥反应的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号